Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dental adhesive system to prevent discoloration after CTZ pulpotomy/root canal treatment in primary molars
RBR-6359s54Recruiting
- Sponsor
- Faculdade de Odontologia de Piracicaba
- Start
- Jan 2025
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of chloramphenicol, tetracycline, zinc oxide and Eugenol in irreversible pulpitis and pulpal necrosis (2 arms), sponsored by Faculdade de Odontologia de Piracicaba. Primary endpoints: Clinical success at 12 months, Radiographic success at 12 months and 1 more. Started Jan 2025; status: recruiting.
02
Drugs
chloramphenicoltetracyclinezinc oxideEugenol
03
Conditions
irreversible pulpitispulpal necrosis
Beyond the preview
Go deeper on RBR-6359s54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6359s54.